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Isolated ventricular non-compaction (IVNC) is a rare, congenital, unclassified cardiomyopathy charac-
terized by prominent trabecular meshwork and deep recesses. Major clinical manifestations of IVNC
are heart failure, atrial and ventricular arrhythmias, and thrombo-embolic events. We describe a
case of a 69-year-old woman in whom the diagnosis of IVNC was discovered late, whereas former echo-
cardiographic examinations were considered normal. She was known for systolic left ventricular dys-
function for 3 years and then became symptomatic (NYHA III). In the past, she suffered from multiple
episodes of deep vein thrombosis and pulmonary embolism. Electrocardiogram revealed a wide QRS
complex, and transthoracic echocardiography showed typical apical thickening of the left and right ven-
tricular myocardial wall with two distinct layers. The ratio of non-compacted to compacted myocardium
was .2:1. Cardiac MRI confirmed the echocardiographic images. Cerebral MRI revealed multiple
ischaemic sequellae. In view of the persistent refractory, heart failure in medical treatment of patients
with classical criteria for cardiac re-synchronization therapy, as well as the ventricular arrhythmias, a
biventricular automatic intracardiac defibrillator (biventricular ICD) was implanted. The 2-year follow-
up period was characterized by improvement of NYHA functional class from III to I and increasing in left
ventricular function. We hereby present a case of IVNC with favourable outcome after biventricular ICD
implantation. Cardiac re-synchronization therapy could be considered in the management of this
pathology.
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Introduction
Isolated ventricular non-compaction (IVNC) is a rare,
embryonic, developmental anomaly characterized by the
persistence of numerous prominent trabeculations with
interlaced recesses that deeply penetrate the myocardium.
In early embryogenesis, the myocardium is composed of a
loose meshwork of individual fibres. Normally, these fibres
undergo progressive compaction.1 This disorder is probably
caused by an arrest in the normal development.
Isolated ventricular non-compaction is usually diagnosed
using Doppler echocardiography with the presence of
numerous prominent hypertrabeculations and multiple
intertrabecular recesses perfused from the ventricular
cavity. A valid diagnosis can be made when the non-
compacted to the compacted layer ratio is higher than 2,
as observed by Chin et al.2 at the end of the diastole or
by Jenni et al.3 at the end of the systole.
Isolated ventricular non-compaction clinical manifes-
tations are non-specific. Nevertheless, three key signs are
usually observed. Heart failure, caused principally by
severe systolic dysfunction of the left ventricle, is seen in
30–70% of cases. Thrombo-embolic events occur in 7–38%
of cases, leading to both pulmonary embolisms and
strokes.2 Cardiac arrhythmias can occur including ventricu-
lar and supraventricular tachycardia as well as atrial fibrilla-
tion. These disorders can lead to syncopes and sudden death
in up to 18% of patients in the observed populations.4 Both
sporadic and familial forms have been described, although
the latter are less frequent.
Case report
A 69-year-old female patient consulted our emergency
department in 2006, following the fourth occurrence of
syncope in 6 months. Patient history included multiple epi-
sodes of deep vein thrombosis without factor V Leiden
mutation or other recognized procoagulant condition. Cer-
ebral MRI with diffusion-weighted imaging showed
T2-weighted hyperintense sequelar ischaemic lesions in
semioval centres and cortico-subcortical area. She suffered
from heart failure. The treatment consisted of angiotensin-
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receptor blocker and loop diuretics. Owing to side effects,
neither beta blockers nor ACE inhibitors were introduced.
Deep vein thrombosis risk of recurrence was treated with
acenocoumarol and a platelet antiaggregant. There was no
sign of neuromuscular disease.
Initial cardiopulmonary auscultation was normal.
Advanced coronary disease has been ruled out by coronary
arteriography. The electrocardiogram revealed sinus
rhythm and left bundle branch block with QRS duration of
178 ms. Holter monitoring showed ventricular extrasystoles
and bursts of ventricular tachycardia of up to five com-
plexes. During hospitalization, she also developed one
episode of supraventricular tachycardia up to 143 b.p.m.,
treated by medical cardioversion. Arrhythmia could be
responsible for syncope. Moderate mitral valve insufficiency
could also be seen by transthoracic echocardiography. The
left ventricle was slightly dilated (end-diastolic volume
100 mL/m2). Diffuse hypokinesia was present with a
marked decrease in systolic function (LVEF 35%, calculated
with the Simpson method). The apical region contained a
hypertrabeculation with intertrabecular recesses interrupt-
ing the hypertrophic muscle bands (Figure 1, see Sup-
plementary data online, Movie S1). These modifications
extended up to the apical region of the right ventricle.
In addition, the patient showed echocardiographic criteria
of intra- and inter-ventricular dyssynchrony as described in
the CARE-HF study:5 aortic pre-ejection delay was 175 ms
and intraventricular mechanical delay was 65 ms. Further-
more, the delay between the interventricular septum and
the postero-lateral wall of the left ventricle exceeded
130 ms. Based on cardiac MRI, the thinning of the compacted
myocardium was measured at 4 mm and the width of trabe-
culations present in the apical segments reached 11 mm
(ratio 2.75:1). The remainder of the left ventricular wall
was measured between 15 and 18 mm. The thickness of
the right ventricle ranged between 3 and 4 mm.
On the basis of these findings, the patient was diagnosed
with IVNC.
In 1990, an echocardiogram performed in order to investi-
gate a heart murmur was described as normal, without any
left ventricular dysfunction or dilatation. The left ventricular
walls were not thickened. Nevertheless, the quality of the
images retrieved from the archives was not sufficient for
exclusion of any a posteriori observation of non-compaction.
Angina-like symptoms appeared in 1999, although coronary
angiogram was normal. A left ventriculography performed
at that time showed lower and apical hypokinesia associated
with left ventricular dysfunction. Following the exclusion
of common causes, the patient was diagnosed with dilated
cardiomyopathy of unknown origin.
In summary, this patient had a high risk of sudden death
due to underlying cardiomyopathy and moderate to severe
left ventricular dysfunction. Moreover, she fulfilled the
electrical and echocardiographic criteria for cardiac
re-synchronization therapy.5 Thus, she received a biventri-
cular ICD.
Twenty-four months clinical outcome was favourable with
an improvement in heart failure symptoms (from NYHA class
III to class I). We did not change the medical treatment of
heart failure. The LVEF increased from 35 to 50%, but oppo-
sitely to the case report of Sto¨llberger et al.6 in similar con-
dition, the level of non-compaction remained unchanged.
The biventricular ICD did not record any new significant
arrhythmia.
Discussion
The term ‘non-compaction’ appeared in 1990 in a echocar-
diographic and histological description by Chin et al.2 The
chosen terminology presupposes the congenital aetiology.
In non-compaction associated with other cardiac or extra-
cardiac anomalies, the physiopathological mechanism
implies that during embryogenesis the left ventricle is
exposed to high blood pressure.4 Histological analysis
revealed no contact—in contrast to patients with persistent
sinusoids—with the coronary network.7 The mechanism is
not yet completely understood. As reminded by Sto¨llberger
et al., even the concept that non-compaction originates
with an embryogenic defect is not definitively proven.8 In
fact, they also described cases of acquired non-
compaction.9 Thus, they proposed the term ‘hypertrabecu-
lation’ instead of non-compaction.
Jenni et al.3 reported a 0.014% IVNC prevalence in echo-
cardiograms performed over 15 years. Overall, there are
strong variations in the figures published in the literature.10
IVNC prevalence in the general population is probably
underestimated.
There is no specific treatment for IVNC. Heart failure
should be treated. Because of the thrombo-embolic risks
linked to auricular fibrillation and of the significant
reduction in the left ventricular ejection volume, the
administration of acenocoumarol as an anticoagulant has
been proposed in many cases.7,11,12 The occurrence of ven-
tricular tachycardia and the high incidence of sudden death
call for an in-depth assessment of arrhythmia risks and an
aggressive treatment in life-threatening situations. Accord-
ing to Jenni et al. an early implantation of ICD may reduce
sudden death event rate, although no specific study demon-
strated definitive benefit. Recently, a positive conclusion
has been reached in a retrospective study of 12 patients
(mean age: 45 years), with one of two patients benefiting
from ICD implantation.13
Figure 1 Apical four-chamber view. Prominent trabeculations at
the apex of the left ventricle are clearly visible. The location
in apical segment is typical for IVNC. A ratio of non-compacted/
compacted myocardium 2 is diagnostic for IVNC.
A. Garnier and G. Girod714
 at Bibliotheque Cantonale et U
niversitaire on A
ugust 12, 2014
http://ehjcimaging.oxfordjournals.org/
D
ow
nloaded from
 
Conclusion
Isolated ventricular non-compaction was not detected in the
patient in spite of multiple echocardiographies performed
over a period of 16 years. This observation suggests that
this condition may be acquired, or at the very least, that
the clinical manifestations of a congenital abnormality can
appear late in life. It is also possible that this diagnosis
was missed in 1990—even though the first and the last exam-
ination were performed by the same sonographer—for two
reasons: the low awareness to this condition and the lower
echocardiographic performances. We believe that cardiac
dyssynchrony should be systematically investigated,
especially in case with symptoms of heart failure. As demon-
strated in our patient and in other papers, biventricular ICD
can be considered as a part of the management of IVNC.6,14
Supplementary data
Supplementary data are available at European Journal of
Echocardiography online.
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